Drug intelligence / Profile preview

propranolol + cortisol

Development stage
Preclinical
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

This is a combination of two agents, propranolol and cortisol. Propranolol is a non-selective beta-adrenergic receptor antagonist (beta blocker) widely used to treat hypertension, angina pectoris, arrhythmias, migraine prophylaxis, essential tremor, anxiety symptoms, and other conditions. It works by blocking beta-1 and beta-2 adrenergic receptors in the heart and vasculature, reducing sympathetic nervous system activity. Cortisol is an endogenous glucocorticoid hormone produced by the adrenal cortex; it regulates metabolism, immune response modulation, stress response via activation of the hypothalamic-pituitary-adrenal (HPA) axis, and has anti-inflammatory effects. There are no approved pharmaceutical products combining propranolol with exogenous cortisol as a fixed-dose medication or branded product. However, experimental paradigms have studied their combined effects on stress physiology in humans—propranolol suppresses sympathetic nervous system reactivity while allowing for increased HPA axis/cortisol responses under acute psychosocial stress[1][6][8]. In animal models of chronic glucocorticoid exposure (using corticosterone), propranolol has been shown to mitigate cognitive deficits and reduce amyloid pathology[3].

Other names
propranolol and cortisol
02

Targets

GR (Glucocorticoid receptor)ADRB2 (β2)ADRB1 (β1)

Beyond the preview

Go deeper on propranolol + cortisol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on propranolol + cortisol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call